135 related articles for article (PubMed ID: 29221277)
21. The association between clinical parameters and resectability in stage III non-small cell lung cancer, and a combination of N2 lymph node burden and lung immune prognostic index score as a potential biomarker.
Kim S; Lim JU; Kang HS; Shin AY; Yeo CD; Kim SK; Park CK; Kim SJ; Lee SH; Kim JW
Transl Lung Cancer Res; 2023 Jan; 12(1):79-95. PubMed ID: 36762065
[TBL] [Abstract][Full Text] [Related]
22. High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients.
Ludovini V; Bianconi F; Siggillino A; Vannucci J; Baglivo S; Berti V; Tofanetti FR; Reda MS; Bellezza G; Mandarano M; Belladonna ML; Metro G; Chiari R; Sidoni A; Puma F; Minotti V; Roila F
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33671892
[TBL] [Abstract][Full Text] [Related]
23. Sublobar Resection versus Stereotactic Body Radiation Therapy for Clinical Stage I Non-Small Cell Lung Cancer: A Study Using Data from the Korean Nationwide Lung Cancer Registry.
Yun J; Cho JH; Hong TH; Yang K; Ahn YC; Kim HK; ;
Cancer Res Treat; 2023 Oct; 55(4):1171-1180. PubMed ID: 37080606
[TBL] [Abstract][Full Text] [Related]
24. Postoperative C-reactive Protein Is a Predictive Biomarker for Survival After Non-small Cell Lung Cancer Resection.
Shinohara S; Otsuki R; Onitsuka T; Machida K; Matsuo M; Nakagawa M; Sugaya M
Anticancer Res; 2019 Apr; 39(4):2193-2198. PubMed ID: 30952767
[TBL] [Abstract][Full Text] [Related]
25. Early Distant Recurrence in Patients With Resected Stage I Lung Cancer: A Case Series of "Blast Metastasis".
Ekeke CN; Mitchell C; Schuchert M; Dhupar R; Luketich JD; Okusanya OT
Clin Lung Cancer; 2021 Jan; 22(1):e132-e135. PubMed ID: 33144072
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for both recurrence and survival in patients with pathological stage I non-small-cell lung cancer.
Kozu Y; Maniwa T; Takahashi S; Isaka M; Ohde Y; Nakajima T
Eur J Cardiothorac Surg; 2013 Jul; 44(1):e53-8. PubMed ID: 23557919
[TBL] [Abstract][Full Text] [Related]
27. Development and validation of a preoperative prognostic index independent of TNM stage in resected non-small cell lung cancer.
Kumagai S; Marumo S; Arita M; Yamanashi K; Sumitomo R; Otake Y; Shoji T; Fukui M; Katayama T; Okumura N; Huang CL
BMC Pulm Med; 2017 Dec; 17(1):166. PubMed ID: 29202834
[TBL] [Abstract][Full Text] [Related]
28. Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial.
Westeel V; Foucher P; Scherpereel A; Domas J; Girard P; Trédaniel J; Wislez M; Dumont P; Quoix E; Raffy O; Braun D; Derollez M; Goupil F; Hermann J; Devin E; Barbieux H; Pichon E; Debieuvre D; Ozenne G; Muir JF; Dehette S; Virally J; Grivaux M; Lebargy F; Souquet PJ; Freijat FA; Girard N; Courau E; Azarian R; Farny M; Duhamel JP; Langlais A; Morin F; Milleron B; Zalcman G; Barlesi F
Lancet Oncol; 2022 Sep; 23(9):1180-1188. PubMed ID: 35964621
[TBL] [Abstract][Full Text] [Related]
29. Prognostic stratification model for patients with stage I non-small cell lung cancer adenocarcinoma treated with surgical resection without adjuvant therapies using metabolic features measured on F-18 FDG PET and postoperative pathologic factors.
Kang YK; Song YS; Cho S; Jheon S; Lee WW; Kim K; Kim SE
Lung Cancer; 2018 May; 119():1-6. PubMed ID: 29656743
[TBL] [Abstract][Full Text] [Related]
30. How Are Indeterminate Pulmonary Nodules at Diagnosis Associated with Survival in Patients with High-Grade Osteosarcoma?
Tsoi KM; Lowe M; Tsuda Y; Lex JR; Fujiwara T; Almeer G; Gregory J; Stevenson J; Evans SE; Botchu R; Jeys LM
Clin Orthop Relat Res; 2021 Feb; 479(2):298-308. PubMed ID: 32956141
[TBL] [Abstract][Full Text] [Related]
31. Segmentectomy Provides Comparable Outcomes to Lobectomy for Stage IA Non-small Cell Lung Cancer with Spread through Air Spaces.
Ikeda T; Kadota K; Go T; Misaki N; Haba R; Yokomise H
Semin Thorac Cardiovasc Surg; 2023; 35(1):156-163. PubMed ID: 35149218
[TBL] [Abstract][Full Text] [Related]
32. Surgical Outcomes after Pulmonary Resection for Non-Small Cell Lung Cancer with Localized Pleural Seeding First Detected during Surgery.
Yun JK; Kim MA; Choi CM; Choi SH; Kim YH; Kim DK; Park SI; Kim HR
Thorac Cardiovasc Surg; 2018 Mar; 66(2):142-149. PubMed ID: 26669768
[TBL] [Abstract][Full Text] [Related]
33. Association Between Surgical Quality Metric Adherence and Overall Survival Among US Veterans With Early-Stage Non-Small Cell Lung Cancer.
Heiden BT; Eaton DB; Chang SH; Yan Y; Baumann AA; Schoen MW; Tohmasi S; Rossetti NE; Patel MR; Kreisel D; Nava RG; Meyers BF; Kozower BD; Puri V
JAMA Surg; 2023 Mar; 158(3):293-301. PubMed ID: 36652269
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non-Small-Cell Lung Cancer.
Kim IH; Lee IH; Lee JE; Hong SH; Kim TJ; Lee KY; Kim YK; Kim SJ; Sung SW; Park JK; Yoo IR; Kim YS; Kim JO; Kang JH
Clin Lung Cancer; 2016 Sep; 17(5):e31-e43. PubMed ID: 26992846
[TBL] [Abstract][Full Text] [Related]
35. Clinical utility of psoas muscle volume in assessment of sarcopenia in patients with early-stage non-small cell lung cancer.
Yamada Y; Shimada Y; Makino Y; Kudo Y; Maehara S; Yamada T; Hagiwara M; Kakihana M; Ohira T; Ikeda N
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3277-3285. PubMed ID: 35916994
[TBL] [Abstract][Full Text] [Related]
36. [The prognostic impact of preoperative PET-CT on postoperative recurrence for completely resected stage I non-small cell lung cancer].
Qiang G; Xu R; Liu J; Yan J; Xu Y; Di J; Da J; Liang C; Shi B; Guo Y; Liu D
Zhonghua Wai Ke Za Zhi; 2015 Jul; 53(7):502-7. PubMed ID: 26359072
[TBL] [Abstract][Full Text] [Related]
37. Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.
Hyun SH; Choi JY; Kim K; Kim J; Shim YM; Um SW; Kim H; Lee KH; Kim BT
Ann Surg; 2013 Feb; 257(2):364-70. PubMed ID: 22968069
[TBL] [Abstract][Full Text] [Related]
38. Impact of genetic status on the survival outcomes of patients with clinical stage I non-small cell lung cancer with a radiological pure-solid appearance.
Sun K; Li M; Shang M; Su X; Zhao J; Wang B; Wu C; Zhang L; Yang S; Sun X
Lung Cancer; 2022 Apr; 166():63-69. PubMed ID: 35196635
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of positron emission tomography in resected stage IA non-small cell lung cancer.
Chou HP; Lin KH; Huang HK; Lin LF; Chen YY; Wu TH; Lee SC; Chang H; Huang TW
Eur Radiol; 2021 Oct; 31(10):8021-8029. PubMed ID: 33763721
[TBL] [Abstract][Full Text] [Related]
40. Effect of comorbidities on long-term outcomes after thoracoscopic surgery for stage I non-small cell lung cancer patients with chronic obstructive pulmonary disease.
Shibazaki T; Odaka M; Noda Y; Tsukamoto Y; Mori S; Asano H; Yamashita M; Morikawa T
J Thorac Dis; 2018 Feb; 10(2):909-919. PubMed ID: 29607164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
